GEODE CAPITAL MANAGEMENT, LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 172 filers reported holding GW PHARMACEUTICALS PLC in Q2 2017. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$6,029,000
+92.0%
27,797
+2.1%
0.00%0.0%
Q4 2020$3,140,000
+24.5%
27,215
+5.0%
0.00%
Q3 2020$2,523,000
-19.6%
25,925
+1.3%
0.00%
-100.0%
Q2 2020$3,139,000
+53.2%
25,584
+9.3%
0.00%0.0%
Q1 2020$2,049,000
-56.8%
23,399
-48.5%
0.00%
Q4 2019$4,748,000
+85.3%
45,414
+103.8%
0.00%
-100.0%
Q3 2019$2,563,000
-33.4%
22,287
-0.2%
0.00%0.0%
Q2 2019$3,851,000
+14.1%
22,341
+11.5%
0.00%0.0%
Q1 2019$3,376,000
-6.3%
20,032
-45.9%
0.00%0.0%
Q4 2018$3,602,000
+12.0%
37,004
+98.6%
0.00%0.0%
Q3 2018$3,217,000
+24.7%
18,628
+0.7%
0.00%0.0%
Q2 2018$2,580,000
+48.3%
18,496
+19.7%
0.00%0.0%
Q1 2018$1,740,000
-13.5%
15,451
+1.4%
0.00%0.0%
Q4 2017$2,011,000
+27.6%
15,241
-1.9%
0.00%0.0%
Q3 2017$1,576,000
+2.6%
15,531
+1.4%
0.00%0.0%
Q2 2017$1,536,000
+6.8%
15,323
+28.8%
0.00%0.0%
Q1 2017$1,438,000
+51.1%
11,893
+39.5%
0.00%
Q4 2016$952,000
+10.4%
8,525
+31.2%
0.00%
Q3 2016$862,000
+55.0%
6,497
+7.0%
0.00%
Q2 2016$556,000
+26.9%
6,0720.0%0.00%
Q1 2016$438,000
+6.6%
6,072
+2.4%
0.00%
Q4 2015$411,000
-10.8%
5,931
+17.3%
0.00%
Q3 2015$461,000
-5.9%
5,056
+26.6%
0.00%
Q2 2015$490,000
+44.5%
3,994
+7.1%
0.00%
Q1 2015$339,000
+62.2%
3,730
+20.3%
0.00%
Q4 2014$209,0000.0%3,101
+19.7%
0.00%
Q3 2014$209,0002,5900.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2017
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 86,069$18,668,0008.69%
BARDIN HILL MANAGEMENT PARTNERS LP 170,108$36,897,0006.84%
HARVEST MANAGEMENT LLC 44,100$9,565,0005.72%
Twin Securities, Inc. 39,541$8,576,0005.50%
TIG Advisors, LLC 572,743$124,228,0004.67%
ALPINE ASSOCIATES MANAGEMENT INC. 787,500$170,810,0004.63%
First Trust Capital Management L.P. 105,822$22,953,0004.49%
Pentwater Capital Management LP 2,102,104$455,946,0004.35%
OMNI PARTNERS LLP 403,061$87,424,0004.31%
SPRING CREEK CAPITAL LLC 370,000$80,253,0003.47%
View complete list of GW PHARMACEUTICALS PLC shareholders